27 results
424B5
IFRX
InflaRx N.V.
28 Jun 24
Prospectus supplement for primary offering
4:56pm
, and in the future if approved for commercial use in the United States or elsewhere;
our ability to successfully implement The InflaRx Commitment Program
6-K
EX-99.1
IFRX
InflaRx N.V.
28 Jun 24
Leerink Partners LLC
4:55pm
, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any share capital of the Company or any
6-K
EX-99.1
IFRX
InflaRx N.V.
24 Jun 24
Current report (foreign)
4:16pm
ability to successfully implement The InflaRx Commitment Program, the success of our future clinical trials for vilobelimab’s treatment of COVID-19
6-K
EX-99.1
IFRX
InflaRx N.V.
5 Jun 24
InflaRx Hosts R&D Event Highlighting the Promise of INF904
5:07pm
implement The InflaRx Commitment Program, the success of our future clinical trials for vilobelimab’s treatment of COVID-19 and other debilitating
6-K
EX-99.2
IFRX
InflaRx N.V.
5 Jun 24
InflaRx Hosts R&D Event Highlighting the Promise of INF904
5:07pm
The InflaRx Commitment Program, the success of our future clinical trials for vilobelimab’s treatment of COVID-19 and other debilitating or life-threatening
6-K
EX-99.1
p0gae4ybx 8xc403tu
21 May 24
Report of Foreign Private Issuer
4:15pm
6-K
EX-99.2
uotzpr
8 May 24
Report of Foreign Private Issuer
8:43am
6-K
EX-99.3
5wvd75oal
8 May 24
Report of Foreign Private Issuer
8:43am
6-K
EX-99.1
0kndeyui
21 Mar 24
Corporate Presentation March 2024
5:00pm
6-K
EX-99.1
g4vu26haqa2 4oc9
21 Mar 24
InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
7:05am
6-K
td7qoykib5 mqww
25 Jan 24
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
8:00am
6-K
EX-99.1
bdq94xq
25 Jan 24
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
8:00am
6-K
EX-1.1
d6wlb 442r
13 Apr 23
Current report (foreign)
4:01pm
6-K
EX-99.1
940o6i
21 May 21
Tony Gibney Joins InflaRx Board of Directors
8:16am
6-K
EX-99.1
hfr526fnfc28 uzz
1 Mar 21
Current report (foreign)
12:00am
6-K
bjgl56jz5x1 ag9a55
24 Feb 21
Current report (foreign)
4:16pm
6-K
EX-99.1
vgohc6092bjgqhxxl
20 Jul 20
from 6-K
9:02am